©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2013; 19(32): 5286-5294
Published online Aug 28, 2013. doi: 10.3748/wjg.v19.i32.5286
Published online Aug 28, 2013. doi: 10.3748/wjg.v19.i32.5286
Table 3 Comparison of the somatic phenotype and genotype as a function of the patient’s clinical characteristics
| MSI (n = 10) | KRAS mutations (n = 16) | TP53 mutations (n = 28) | TP53 overexpression (n = 21) | MUC5AC overexpression (n = 15) | |
| Mean age at diagnosis (range), yr | 45 (18-72) | 51.5 (18-85) | 48.5 (18-79) | 49.5 (24-75) | 50 (24-76) |
| Sex | |||||
| Males | 80.00% | 75.00% | 57.10% | 52.40% | 66.70% |
| Females | 20.00% | 25.00% | 42.90% | 47.60% | 33.30% |
| Tumor site1 | |||||
| Proximal | 50.00% | 18.80% | 21.40% | 28.60% | 33.30% |
| Distal | 50.00% | 81.30% | 78.60% | 71.40% | 66.70% |
| TNM stage2 | |||||
| I | 10.00% | 6.30% | 0.00% | 0.00% | 0.00% |
| II | 40.00% | 43.80% | 48.10% | 38.10% | 40.00% |
| III | 50.00% | 50.00% | 44.40% | 47.60% | 53.30% |
| IV | 0.00% | 0.00% | 7.40% | 9.50% | 6.70% |
- Citation: Aissi S, Buisine MP, Zerimech F, Kourda N, Moussa A, Manai M, Porchet N. Somatic molecular changes and histo-pathological features of colorectal cancer in Tunisia. World J Gastroenterol 2013; 19(32): 5286-5294
- URL: https://www.wjgnet.com/1007-9327/full/v19/i32/5286.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i32.5286